French biotech raises €5m, looks to restore patient response to anticancer immunotherapies 01-Dec-2021 By Jane Byrne EverImmune, a biotech based near Paris, and specialized in the development of live biotherapeutic products in the field of microbiota oncology, has raised €5m (US$5.7m) in a Series A funding round from undisclosed private investors.